-
Dietary fatty acids will accelerate tumor metastasis
Time of Update: 2021-12-02
In this latest study, Salvador Benitah and colleagues of the Institute of Science and Technology in Barcelona, Spain, first exposed human oral cancer and skin cancer cells to three dietary fatty acids-palmitic acid (the main saturated fatty acid in palm oil), Either oleic acid or linoleic acid-the exposure time is 4 days, and then these cells are transplanted into the corresponding tissues of mice fed a standard diet .
-
Whole genome sequencing improves rare disease diagnosis rate
Time of Update: 2021-12-02
The study involved 319 families with suspected mitochondrial diseases, with a total of 345 participants, ranging in age from 0 to 92 years old, with an average age of 25 years old, all of which were sequenced .
-
Scientists find for the first time that interleukin 27 signaling can burn fat
Time of Update: 2021-12-02
Scientists find for the first time that interleukin 27 signaling can burn fat Scientists discover for the first time that interleukin 27 signaling can burn fat Yin Zhinan's team at Jinan University found a new target for weight loss to burn calories when lying flat?
(Source: Zhu Hanbin, China Science News ) https://doi.
1038/s41586-021-04127-5 https://doi.
org/10.
org/10.
-
Low-cost single-molecule peptide sequencing is expected
Time of Update: 2021-12-02
Recently, the team of Bai Jingwei, a researcher at the School of Pharmacy of Tsinghua University, used helicase to control the movement of DNA, and then controlled the peptides linked to it to pass through a nanopore in a linear sequence of amino acids, and detected its amino acid sequence through changes in electrical signals .
-
Latest research: Chimeric embryos can also successfully give birth to test-tube babies
Time of Update: 2021-12-02
" The researchers hope that this study will immediately affect clinical practice, prompt relevant departments to update guidelines and recommendations, and allow patients undergoing IVF to improve the decision-making process when evaluating chimeric embryo transfer .
-
Report on the latest situation of the new coronavirus pneumonia on the 29th
Time of Update: 2021-12-01
As of 24:00 on November 29, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 790 confirmed cases (including 7 severe cases), a total of 93,285 cured and discharged cases, and a total of 4,636 deaths.
-
A hospital pre-purchased 3.7 million nucleic acid flight mass spectrometers-to ensure medical inspection, biological diagnosis and treatment work
Time of Update: 2021-12-01
Analysis and Testing Encyclopedia News November 30, 2021 The Second Affiliated Hospital of Xi'an Jiaotong University announced the government procurement intention.
-
Russia's research and development of new prostate cancer drugs is 80% effective
Time of Update: 2021-12-01
The Russian National Research University "Moscow State Institute of Steel and Alloys" announced that a team of scientists from Russia's leading universities has developed drugs for the treatment of prostate cancer with a treatment efficiency of 80% .
-
This pharmaceutical company has received a financing of 100 million yuan to accelerate the construction of production bases and the research and development of new products
Time of Update: 2021-11-15
The research and development of new products, while consolidating the small molecule innovative drug CDMO business, further accelerates the conversion of the core raw material business in the IVD field .
-
With an investment of more than 4 billion yuan, Fosun Pharma will further enrich the vaccine product pipeline
Time of Update: 2021-11-15
According to the current development trend, the industry predicts that with the continuous enrichment of vaccine varieties and the continuous improvement of accessibility, as well as the increase of per capita income and the increase of people’s awareness of vaccination, China’s vaccine market will continue to maintain a rapid growth trend in the future.
-
Biopharmaceutical company Liantuo Bio will go public in the United States, valued at approximately US$1.8 billion
Time of Update: 2021-11-15
According to the terms of the agreement, Liantuo Bio will obtain commercialization rights in China and designated Asian markets, and participate in the clinical research and development of infigratinib and BBP-398 .
-
Ruizhi Pharmaceutical will build a production base in Suzhou to further increase preclinical CRO production capacity
Time of Update: 2021-11-15
It is worth mentioning that in the future, as the penetration rate of domestic innovative drug R&D outsourcing continues to increase, more and more companies will also deploy in this field to promote the further development of the domestic CRO industry .
-
136 million!
Time of Update: 2021-11-15
Kailaiying issued an announcement on the evening of October 24, stating that the company’s wholly-owned subsidiary, Kainuo Pharmaceutical, intends to acquire 100% of the shares held by the original shareholders of Yipu Kenuo with its own funds of 136 million yuan.
-
Tuoxin Pharmaceutical officially landed on the GEM, focusing on the field of nucleosides (acids)
Time of Update: 2021-11-15
The company has domestic nucleoside (acid) APIs and The R&D field of pharmaceutical intermediates started early, with large scale and complete varieties, and has formed a relatively complete product chain from basic products to high-end products .
-
Shanghai Lu Xiangyi delivered a batch of automatic positioning centrifuges to assist in the review of IVD-related equipment licenses
Time of Update: 2021-11-15
At present, Shanghai Lu Xiangyi has customized a number of domestic leading companies in the industry, and has provided reliable automatic positioning centrifuges for solving the overall solution of in vitro diagnosis .
-
336 million yuan!
Time of Update: 2021-11-15
According to the announcement, Yibai Pharmaceutical intends to acquire a 70% stake in Deyang Cancer Hospital Co.
In 2017, Yibai Pharmaceutical issued an announcement stating that it would acquire 90% of the equity of the hospital held by Fulin Group at a consideration of 135 million yuan .
-
To accelerate the development of anti-tumor ADC drugs, Zhenbaodao established a new company
Time of Update: 2021-11-15
On November 1, Treasure Island issued an announcement stating that it plans to establish a wholly-owned subsidiary in Hangzhou Qiantang New District, invest in the company's Hangzhou Biopharmaceutical Project, engage in the research and development of anti-tumor ADC drugs, and establish other subsidiaries and other industries .
-
A new drug for rare skin diseases will be launched in China soon!
Time of Update: 2021-11-15
Recently, Boehringer Ingelheim announced that it has formally submitted a marketing application for the new immunological drug Spesolimab to the Center for Drug Evaluation (CDE) of the China National Medical Products Administration for the treatment of the onset of generalized pustular psoriasis (GPP) .
-
October will end, and another multinational pharmaceutical company will disclose its third-quarter financial report!
Time of Update: 2021-11-15
For example, it can be seen from the 2021 mid-year report that the sales of its Huntington's disease treatment drug Austedo have increased compared with the second quarter of 2020; the global net sales of migraine prevention drug Ajovy have also increased to 70 million US dollars; The market share of similar drugs Truxima in the U.
-
Competition in the TYK2 drug market is intensifying, and Pfizer will sell 2 drugs under development
Time of Update: 2021-11-14
It is understood that, in the field of Tyk2 drugs, BMS's Deucravacitinib is the research product of TyK2 inhibitors with relatively advanced clinical progress in the world .
